Four Orchestra BioMed insiders buy $230,000 of shares in its offering
Orchestra BioMed's chief financial officer, chief executive and two directors bought 46,000 shares at $5.00 each in its public offering, filed November 9, 2026.
The purchases
4 insiders
Purchase on Nov 9, filed on Nov 9
4
Buyers
$230k
Bought
0
Sellers
Director
DP
David Pacitti
Buy · $100k · 20,000 shares
+36.5%
EF
Eric S Fain
Buy · $100k · 20,000 shares
+20.1%
Chief executive
DH
David P Hochman
Buy · $25k · 5,000 shares
+1.2%
Chief financial officer
AT
Andrew Lawrence Taylor
Buy · $5k · 1,000 shares
+0.2%
On the right, by how much each one increased the number of shares they own. Purchases declared to the SEC, the US stock market watchdog (Form 4), decided on the spot and not scheduled in advance.
AI analysis
Nov 9
With TrueWallet Pro
Why these purchases matter given where the stock stands, and what they do not say. Upgrade to Pro from the TrueWallet app.